ALL libraries (COBIB.SI union bibliographic/catalogue database)
  • Genetic polymorphism in ATG16L1 gene influences the response to adalimumab in Crohn's disease patients
    Koder, Silvo ...
    Aim: To see if SNPs could help predict response to biological therapy using adalimumab (ADA) in Crohn's disease (CD). Materials & methods: IBDQ index and CRP levels were used to monitor therapy ... response. We genotyped 31 CD-associated genes in 102 Slovenian CD patients. Results: The strongest association for treatment response defined as decrease in CRP levels was found for ATG16L1 SNP rs10210302. Additional SNPs in 7 out of 31 tested CD-associated genes (PTGER4, CASP9, IL27, C11orf30, CCNY, IL13, NR1I2) showed suggestive association with ADA response. Conclusion: Our results suggest ADA response in CD patients is genetically predisposed by SNPs in CD risk genes and suggest ATG16L1 as most promising candidate gene for drug response in ADA treatment.
    Source: Pharmacogenomics. - ISSN 1462-2416 (Vol. 16, no. 3, 2015, str. 191-204)
    Type of material - article, component part
    Publish date - 2015
    Language - english
    COBISS.SI-ID - 512474168
    DOI

source: Pharmacogenomics. - ISSN 1462-2416 (Vol. 16, no. 3, 2015, str. 191-204)
loading ...
loading ...
loading ...